INS and type 2 diabetes mellitus: Kapoor et al. [27] also demonstrated that T therapy in men with T2DM reduced visceral adiposity and reduced homoeostasis model assessment (HOMA) index, HbA1c, and fasting glucose, suggesting improvement in insulin sensitivity and glycaemic control in men with TD and T2DM [27].